Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Costanza Bogani
Observed names:
BOGANI C,
BOGANI C.,
BOGANI, COSTANZA,
Bogani C,
Bogani, C,
C Bogani,
C. Bogani
show all 7
Institution:
University of Florence
Observed institutions:
Mount Sinai Hospital,
Istituto Superiore di Sanità,
University of Chieti-Pescara,
University of Illinois Chicago,
Azienda Ospedaliero-Universitaria Careggi,
Tumour Institute of Tuscany,
University of Florence
show all 7
OpenAlex ID:
A5019598635
Prospective identification of high-risk polycythemia vera patients based on JAK2V617F allele burden
2007
·
A M Vannucchi
, E Antonioli
, et al.
·
Leukemia
·
370
Clinical implications of the JAK2 V617F mutation in essential thrombocythemia
2005
·
E Antonioli
, P Guglielmelli
, et al.
·
Leukemia
·
229
PDF
Influence of JAK2V617F allele burden on phenotype in essential thrombocythemia
2007
·
E. Antonioli
, P. Guglielmelli
, et al.
·
Haematologica
·
163
PDF
Molecular Profiling of CD34+ Cells in Idiopathic Myelofibrosis Identifies a Set of Disease-Associated Genes and Reveals the Clinical Significance of Wilms' Tumor Gene 1 (WT1)
2006
·
Paola Guglielmelli
, Roberta Zini
, et al.
·
Stem Cells
·
128
miRNA-mRNA integrative analysis in primary myelofibrosis CD34+ cells: role of miR-155/JARID2 axis in abnormal megakaryopoiesis
2014
·
Ruggiero Norfo
, Roberta Zini
, et al.
·
Blood
·
126
PDF
Co‐targeting the PI3K/ mTOR and JAK2 signalling pathways produces synergistic activity against myeloproliferative neoplasms
2013
·
Niccolò Bartalucci
, Lorenzo Tozzi
, et al.
·
Journal of Cellular and Molecular Medicine
·
123
PDF
Increased Risk of Lymphoid Neoplasms in Patients with Philadelphia Chromosome–Negative Myeloproliferative Neoplasms
2009
·
Alessandro M. Vannucchi
, Giovanna Masala
, et al.
·
Cancer Epidemiology Biomarkers & Prevention
·
112
PDF
mTOR Inhibitors Alone and in Combination with JAK2 Inhibitors Effectively Inhibit Cells of Myeloproliferative Neoplasms
2013
·
Costanza Bogani
, Niccolò Bartalucci
, et al.
·
PLoS ONE
·
101
PDF
Hypermethylation ofCXCR4Promoter in CD34+ Cells from Patients with Primary Myelofibrosis
2008
·
Costanza Bogani
, Vanessa Ponziani
, et al.
·
Stem Cells
·
95
PDF
MicroRNA expression profile in granulocytes from primary myelofibrosis patients
2007
·
Paola Guglielmelli
, Lorenzo Tozzi
, et al.
·
Experimental Hematology
·
78
A quantitative assay for JAK2V617F mutation in myeloproliferative disorders by ARMS-PCR and capillary electrophoresis
2006
·
A M Vannucchi
, A Pancrazzi
, et al.
·
Leukemia
·
77
Abnormalities of GATA-1 in Megakaryocytes from Patients with Idiopathic Myelofibrosis
2005
·
Alessandro M. Vannucchi
, Alessandro Pancrazzi
, et al.
·
American Journal Of Pathology
·
76
PDF
Targeted cancer exome sequencing reveals recurrent mutations in myeloproliferative neoplasms
2013
·
on behalf of AGIMM investigators
, E Tenedini
, et al.
·
Leukemia
·
73
PDF
The JAK2V617 mutation induces constitutive activation and agonist hypersensitivity in basophils from patients with polycythemia vera
2009
·
L. Pieri
, C. Bogani
, et al.
·
Haematologica
·
64
PDF
Mitochondrial Expression and Functional Activity of Breast Cancer Resistance Protein in Different Multiple Drug-Resistant Cell Lines
2009
·
Michela Solazzo
, Ornella Fantappiè
, et al.
·
Cancer Research
·
61
Ruxolitinib is an effective treatment for CALR ‐positive patients with myelofibrosis
2015
·
Paola Guglielmelli
, Giada Rotunno
, et al.
·
British Journal of Haematology
·
49
PDF
Variegation of the phenotype induced by the Gata1low mutation in mice of different genetic backgrounds
2005
·
Fabrizio Martelli
, Barbara Ghinassi
, et al.
·
Blood
·
35
Overexpression of microRNA-16-2 contributes to the abnormal erythropoiesis in polycythemia vera
2011
·
Paola Guglielmelli
, Lorenzo Tozzi
, et al.
·
Blood
·
32
PDF
B-, T-, and NK-cell lineage involvement in JAK2V617F-positive patients with idiopathic myelofibrosis
2007
·
C. Bogani
, P. Guglielmelli
, et al.
·
Haematologica
·
28
PDF
Epigenetic therapy in myeloproliferative neoplasms: evidence and perspectives
2009
·
Alessandro M. Vannucchi
, Paola Guglielmelli
, et al.
·
Journal of Cellular and Molecular Medicine
·
25
PDF
Influence of the Jak2V617F Mutational Load at Diagnosis on Major Clinical Aspects in Patients with Polycythemia Vera.
2006
·
Alessandro M. Vannucchi
, Elisabetta Antoniolim
, et al.
·
Blood
·
19
β3-Adrenoreceptor Blockade Reduces Hypoxic Myeloid Leukemic Cells Survival and Chemoresistance
2020
·
Maura Calvani
, Annalisa Dabraio
, et al.
·
International Journal of Molecular Sciences
·
18
PDF
Mesenchymal stem cells from JAK2V617F mutant patients with primary myelofibrosis do not harbor JAK2 mutant allele
2007
·
Lisa Pieri
, Paola Guglielmelli
, et al.
·
Leukemia Research
·
18
RAD001, An Inhibitor of mTOR, Shows Clinical Activity in a Phase I/II Study in Patients with Primary Myelofibrosis (PMF) and Post Polycythemia Vera/Essential Thrombocythemia Myelofibrosis (PPV/PET MF).
2009
·
Alessandro M. Vannucchi
, Paola Guglielmelli
, et al.
·
Blood
·
17
The mTOR Inhibitor, RAD001, Inhibits the Growth of Cells From Patients with Myeloproliferative Neoplasms.
2009
·
Alessandro M. Vannucchi
, Costanza Bogani
, et al.
·
Blood
·
16
Show more works
View as search
Works count:
61
Citation count:
2,202
H-index:
20
I10-index:
28
Year
Topic
Type
